Memorial University of Newfoundland   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: St. John's Canada (1925)

Organization Overview

First Clinical Trial
2003
NCT00200226
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dorothy Bautista, MD | Eastern Health, HSC, Memorial University | Faculty, Discipline Obstetrics and Gynecolgy, Memorial University of Newfoundland | Faculty, Discipline Obstetrics and Gynecology, Memorial University of Newfoundland | Memorial University | Memorial University of Newfoundland | Memorial University of Newfoundland and Labrador | Memorial University Orthopaedic Surgery | Ocean Frontier Institute | Resident, Discipline Obstetrics and Gynecology, Memorial University of Newfoundland | Resident, Obstetrics and Gynecology, Memorial University of Newfoundland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 4)

Brain Diseases (Phase 2)

Brain Infarction (Phase 2)

Brain Ischemia (Phase 2)

Central Nervous System Diseases (Phase 2)

Cerebral Infarction (Phase 2)

Cerebrovascular Disorders (Phase 2)

Clostridium Infections (Phase 3)

Conjunctivitis (Phase 3)

Diarrhea (Phase 3)

Glomerulonephritis, IGA (Phase 1)

Infarction (Phase 2)

Kidney Diseases (Phase 4)

Nervous System Diseases (Phase 2)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Proteinuria (Phase 1)

Renal Insufficiency (Phase 4)

Skin Diseases, Genetic (Phase 3)

Stroke (Phase 2)

Vascular Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 18